Not so critical appraisal of dapagliflozin
Sheila A Doggrell School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD, AustraliaA recent review by Salvo et al published in Patient Preference and Adherence concerned dapagliflozin, and was titled “Patient considerations in the management of...
Main Author: | Doggrell SA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-08-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/not-so-critical-appraisal-of-dapagliflozin-peer-reviewed-article-PPA |
Similar Items
-
Patient considerations in the management of type 2 diabetes – critical appraisal of dapagliflozin
by: Salvo MC, et al.
Published: (2014-04-01) -
A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects
by: Kim HC, et al.
Published: (2023-04-01) -
Is Dapagliflozin future for CKD?
by: Yumna Zafar, et al.
Published: (2022-02-01) -
Exenatide extended-release; clinical trials, patient preference, and economic considerations
by: Doggrell SA
Published: (2013-01-01) -
Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin
by: Doggrell SA
Published: (2014-04-01)